Mantadix and pulmonary sarcoidosis Patient Reports February 09, 2012

Mantadix Side Effects Report #5076275-5
Mantadix side effect was reported by a Pharmacist from FRANCE on July 28, 2006. Female patient, 65 years of age, was diagnosed with hepatitis c , neutropenia, prophylaxis and was treated with Mantadix. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, platelet count decreased, pulmonary sarcoidosis. Mantadix dosage: 200MG DAILY PO. During the same period patient was treated with PEGASYS, COPEGUS, GRANOCYTE, GLYBURIDE, LORAZEPAM. Patient was hospitalized. Patient recovered.